Nov 3, 2015 by Brian FeroldiWhy NxStage Medical Inc.'s Shares Are Soaring HigherBetter-than-expected results combined with an increase in guidance caused the stock to jump.
Nov 3, 2015 by Brian FeroldiWhy Tetraphase Pharmaceuticals Shares Are Soaring TodayA mixed earnings report combined with a small dash of hope have investors feeling bullish on this beaten-down stock.
Nov 3, 2015 by Brian Feroldi, Sean Williams, Dan Caplinger, Matt Frankel, CFP, and Todd Campbell5 Income Juggernauts You Can Safely Buy in Your 80sOur contributors think that these five stocks are a great choice for investors looking for income.
Nov 2, 2015 by Brian Feroldi, Selena Maranjian, Sean Williams, Dan Caplinger, and Matt Frankel, CFP5 Best Dividend Stocks To Buy In NovemberAre you on the hunt for a stock that pays a dividend? Our contributors think these names deserve a look.
Nov 2, 2015 by Brian FeroldiWhy Acadia Pharmaceuticals Is Up TodayInvestors get excited about good news from the FDA, sending shares higher.
Nov 2, 2015 by Brian FeroldiWhy Dyax Corp. Is Soaring 30% Higher TodayAn announced takeover agreement sends shares of the biotech soaring.
Nov 2, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Things You Never Knew About MedicareOur contributors think that Medicare recipients of all ages should be aware of these Medicare facts.
Nov 1, 2015 by Brian FeroldiThe Top 3 Biotech ETFs on the MarketAre you interested in biotech stocks, but don't want to pick them individually? Then you should give these three biotech ETFs a look.
Nov 1, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Biotech Stocks to Buy in NovemberOur Motley Fool contributors think that these 3 biotech stocks are great buys right now.
Nov 1, 2015 by Brian Feroldi, Selena Maranjian, Sean Williams, Dan Caplinger, and Cheryl Swanson5 Healthcare Trends to Invest in for the Next 20 YearsOur contributors think that healthcare-focused investors should watch these 5 long-term healthcare trends.
Nov 1, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhDThese Drugs Could Deliver $5 Billion (or More) in Annual SalesOur contributors think that these drugs that are currently in clinical trials hold enormous sales potential.
Oct 31, 2015 by Brian Feroldi, Sean Williams, and Jason Hall3 Popular Stocks That Have Us SpookedAre these 3 stocks more trick than treat?
Oct 30, 2015 by Brian FeroldiWhy Fluidigm Corporation is Soaring HigherA beat on revenue and earnings sends shares of this beat-down company higher.
Oct 30, 2015 by Brian Feroldi6 Billion Reasons This Biotech Is a BuyThe revenue potential of this company's lead product candidate looks astounding.
Oct 29, 2015 by Brian FeroldiDid Keryx Biopharmaceuticals Inc Finally Turn The Corner?A good-looking quarterly report sends shares higher, but is this the start of a trend or a one time anomaly?
Oct 28, 2015 by Brian FeroldiWhy Walgreens Boots Alliance Investors Are Seeing Red TodayConfirmation about its acquisiton of Rite Aid combined with mixed quarterly results send shares lower.
Oct 28, 2015 by Brian FeroldiWhy Cempra Inc is Up Big TodayAn updated investor presentation appears to have bulls excited, and shares are soaring today as a result.
Oct 27, 2015 by Brian FeroldiWhy Rite Aid Is Soaring TodayNews of a potential buyout by a rival pharmacy sends shares of the pharmacy parabolic.
Oct 27, 2015 by Brian FeroldiWhy CTI BioPharma Corp Shares Are Falling TodayPricing details on a recently announced capital raise have investors selling off shares.
Oct 26, 2015 by Brian FeroldiAlexion Pharmaceuticals Nabs an Approval, Wall Street Not ImpressedAre you not entertained?
